C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/19/2002	WO2002100892A1 Systems and methods for the analysis of proteins
12/19/2002	WO2002100873A1 Processes of purifying oligonucleotides
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100337A2 Antithrombotic thrombin variants
12/19/2002	WO2002100246A2 Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression
12/19/2002	WO2002100172A1 Administration of agents via the pept-2 transporter
12/19/2002	WO2002100163A2 Cotton event moni5985 and compositions and methods for detection
12/19/2002	WO2002100157A2 Method and apparatus for labeling and analyzing cellular components
12/19/2002	WO2002092615A3 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002074079A3 Polynucleotide encoding a gene conferring resistance to bacillus thuringiensis toxins
12/19/2002	WO2002070664A3 Method for rapid detection and identification of bioagents
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002068603A3 Materials and methods for the induction of premature chromosome condensation
12/19/2002	WO2002066682A3 Rat toxicologically relevant genes and uses thereof
12/19/2002	WO2002064780A9 Dna sequences for human tumour suppressor genes
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002057787A3 Detection of survivin in the biological fluids of cancer patients
12/19/2002	WO2002050104A9 Methods and cells for detecting modulators of rgs proteins
12/19/2002	WO2002048334A3 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
12/19/2002	WO2002046457A3 Method for encoding hybridization probes
12/19/2002	WO2002040994A3 System and method for assaying drugs
12/19/2002	WO2002012854A3 Systems and methods for providing information concerning chromophores in physiological media
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
12/19/2002	WO2001079853A3 Test system for characterizing modulators of the splicing process of mrna in living cells (in vivo), production thereof and use thereof
12/19/2002	WO2001079561A9 Alpha-2 adrenergic receptor polymorphisms
12/19/2002	WO2001079481A8 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001073050A9 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	WO2001070948A9 Methods and compositions for elucidating protein expression profiles in cells
12/19/2002	WO2001066795A8 Method for analysing the length of a nucleic acid molecule
12/19/2002	US20020194642 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
12/19/2002	US20020194641 PUFA polyketide synthase systems and uses thereof
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194632 Transgenic knockouts of BACE-1
12/19/2002	US20020193672 Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers
12/19/2002	US20020193581 Allele for use in the diagnosis and treatment of schizophrenia and psychological disorders
12/19/2002	US20020193580 Synthetic nucleotide sequences for use as tools in controlling genetic engineering
12/19/2002	US20020193563 Randomly generated glycopeptide combinatorial libraries
12/19/2002	US20020193457 Microporous membrane, and highly electropositive hydrophilic material capable of irreversibly binding nucleic acids positioned within the membrane
12/19/2002	US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193304 Anti-HIV agents
12/19/2002	US20020193303 58860, a human cholesteryl ester hydrolase and uses therefor
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020192838 Ddetermining pregnancy in animals; obtain animal, monitor expression of pregnancy induced protein, monitor mating of animal, determine amplification in concentration of pregnancy induced protein, amplified concentration indicates pregnancy
12/19/2002	US20020192820 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/19/2002	US20020192819 Generation of preferential nucleotide sequences; obtain nucleotide sequences, incubate with vector, ligate, recover sequences
12/19/2002	US20020192816 Human pancreatic progenitor cells for use in cell therapy
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192793 Isolation of the biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use
12/19/2002	US20020192789 Novel enterokinase cleavage sequences
12/19/2002	US20020192787 Polypeptide for use in the diagnosis, treatment, and prevention of cancer and developmental defects
12/19/2002	US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002	US20020192769 Polymerase chain reaction of DNA of which base sequence is completely unidentified
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192755 Generation of preferential protein in genetically engineered cell; obtain genetically engineeredd cell, express vector, recover protein
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192741 Selective medium for gram-positive bacteria
12/19/2002	US20020192740 Mixing a bacterium having the type III secretory mechanism and an erythrocyte suspension, adding the type III secretory mechanism inhibitor thereto, and detecting changes in the thus formed hemolytic activity
12/19/2002	US20020192738 Detection of tyrosinase in cell or tissue sample; obtain sample, incubate wit tyrosinase substrate, detect signal, presence of signal indicates presence of tyrosinase
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192736 Assay of peroxidase activity
12/19/2002	US20020192734 Used as an additive in a tube to neutralize residual heparin in specimens taken from heparinized patients and accelerate clotting; irradiation stable; for minimizing interference from heparin in a blood sample
12/19/2002	US20020192733 Reagent test strip for analyte determination having a hemolyzing agent
12/19/2002	US20020192732 Determinine concentration of cholesterol in sample; obtain sample, incubate with surfactant, expose to enzyme, determine concentration of cholesterol in high density lipoprotein
12/19/2002	US20020192728 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/19/2002	US20020192726 Detecting modulator of cell proliferation; obtain cell, incubate with modulator, monitor fluorescent emission of luciferase, adjustment in fluorescence indicates modulation
12/19/2002	US20020192725 Diagnosing alzheimer's disease in humans; obtain sample, detect expression of preferential apolipoprotein and estrogen, derease in estrogen concentration with an increase in apolipoprotein concentration indicates alzheimer's
12/19/2002	US20020192719 Detecting preferential particles on solid support; generate solid support, incubate with sample, detect signal, monitor fluorescence
12/19/2002	US20020192715 Test kit for determining process for determining antibiotics containing a beta-lactam ring in a biological fluid
12/19/2002	US20020192710 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
12/19/2002	US20020192709 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192705 Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells
12/19/2002	US20020192700 Classification of cells; obtain cells, incubate with preferential nucleotide sequences, detect hybridzation, classify cells
12/19/2002	US20020192699 Genes and gene expression products that are differentially regulated in prostate cancer
12/19/2002	US20020192698 Detection of cancerous mammay gland cells in sample; obtain cells, extract nucleotide sequences, incubate with probe, detect signal, presence of signal indicates cancer
12/19/2002	US20020192697 Sequencing preferential nucleotide sequences; obtain nucleotide sequence, incubate with reaction mix, expose with polymerase, electrophorese, determine nucleotide sequence of sample
12/19/2002	US20020192696 Using Cdc6 as therapeutic, prognostic and diagnostic targets for cell growth/proliferation
12/19/2002	US20020192695 Detection of modulator of tumor suppressor activity; obtain sample of polypeptide, incubate with modulator, monitor adjustment in polypeptide activity
12/19/2002	US20020192693 Apparatus for polymer synthesis
12/19/2002	US20020192692 Methods of analyzing chromosomal translocations using fluorescence in situ hybridization (FISH)
12/19/2002	US20020192691 Analysis of preferential nucleotide sequence; obtain solid support, generate nucleotide sequences solid support, incubate with sample, expose to probe, detect hybridization signal
12/19/2002	US20020192690 Analysis of preferential polypeptide in sample; obtain sample polypeptide, incubate with antibody bound solid support, detect signal, recover bound polypeptide
12/19/2002	US20020192689 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences
12/19/2002	US20020192688 Imaging nucleic acid delivery
12/19/2002	US20020192687 Bio-barcodes based on oligonucleotide-modified nanoparticles
12/19/2002	US20020192686 Recovery of cells expressing preferential phenotypes; obtain cells, store phenotypic data, monitor phenotypic adjustments in cells, recover and classify phenotypes of interest

1 ... 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 ... 3003